Silverarc Capital Management »

Voyager Therapeutics shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Voyager Therapeutics (VYGR) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Voyager Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Voyager Therapeutics held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Voyager Therapeutics by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $806k 104k 7.75
2023-06-30 $1.1M 100k 11.45

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Voyager Therapeutics

EcoR1 Capital
Vanguard Group
T. Rowe Price Associates
Dimensional Fund Advisors
AQR Capital Management
Federated Investors
D. E. Shaw & Co
Jpmorgan Chase & Co
Ikarian Capital
Fiduciary Trust Company
Bank of New York Mellon
Kestra Advisory Services
ADAR1 Capital Management
Goldman Sachs Group
TD Asset Management

View all funds holding Voyager Therapeutics